{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:24:13Z","timestamp":1787019853375,"version":"build-2736575974"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Various antigen-specific immunoassays are available for the serological diagnosis of autoimmune bullous diseases. However, a spectrum of different tissue-based and monovalent antigen-specific assays is required to establish the diagnosis. BIOCHIP mosaics consisting of different antigen substrates allow polyvalent immunofluorescence (IF) tests and provide antibody profiles in a single incubation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Slides for indirect IF were prepared, containing BIOCHIPS with the following test substrates in each reaction field: monkey esophagus, primate salt-split skin, antigen dots of tetrameric BP180-NC16A as well as desmoglein 1-, desmoglein 3-, and BP230gC-expressing human HEK293 cells. This BIOCHIP mosaic was probed using a large panel of sera from patients with pemphigus vulgaris (PV, n\u2009=\u200965), pemphigus foliaceus (PF, n\u2009=\u200950), bullous pemphigoid (BP, n\u2009=\u200942), and non-inflammatory skin diseases (n\u2009=\u200997) as well as from healthy blood donors (n\u2009=\u2009100). Furthermore, to evaluate the usability in routine diagnostics, 454 consecutive sera from patients with suspected immunobullous disorders were prospectively analyzed in parallel using a) the IF BIOCHIP mosaic and b) a panel of single antibody assays as commonly used by specialized centers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Using the BIOCHIP mosaic, sensitivities of the desmoglein 1-, desmoglein 3-, and NC16A-specific substrates were 90%, 98.5% and 100%, respectively. BP230 was recognized by 54% of the BP sera. Specificities ranged from 98.2% to 100% for all substrates. In the prospective study, a high agreement was found between the results obtained by the BIOCHIP mosaic and the single test panel for the diagnosis of BP, PV, PF, and sera without serum autoantibodies (Cohen\u2019s \u03ba between 0.88 and 0.97).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The BIOCHIP mosaic contains sensitive and specific substrates for the indirect IF diagnosis of BP, PF, and PV. Its diagnostic accuracy is comparable with the conventional multi-step approach. The highly standardized and practical BIOCHIP mosaic will facilitate the serological diagnosis of autoimmune blistering diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/1750-1172-7-49","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T08:14:22Z","timestamp":1344500062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["Serological diagnosis of autoimmune bullous skin diseases: Prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy"],"prefix":"10.1186","volume":"7","author":[{"given":"Nina","family":"van Beek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Rentzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Probst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Komorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kasperkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Fechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga M","family":"Bloecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"St\u00f6cker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,9]]},"reference":[{"key":"476_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1515\/CCLM.2006.027","volume":"44","author":"R Eming","year":"2006","unstructured":"Eming R, Hertl M: Autoimmune bullous disorders. Clin Chem Lab Med. 2006, 44: 144-149.","journal-title":"Clin Chem Lab Med"},{"key":"476_CR2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1084\/jem.20011299","volume":"195","author":"M Sardy","year":"2002","unstructured":"Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N: Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med. 2002, 195: 747-757.","journal-title":"J Exp Med"},{"key":"476_CR3","first-page":"399","volume":"108","author":"E Schmidt","year":"2011","unstructured":"Schmidt E, Zillikens D: The diagnosis and treatment of autoimmune blistering skin diseases. Dtsch Arztebl Int. 2011, 108: 399-405. I-III","journal-title":"Dtsch Arztebl Int"},{"key":"476_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.4103\/0378-6323.82396","volume":"77","author":"AJ Kanwar","year":"2011","unstructured":"Kanwar AJ, De D: Pemphigus in India. Indian J Dermatol Venereol Leprol. 2011, 77: 439-449.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"476_CR5","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1365-2133.2009.09300.x","volume":"161","author":"G Marazza","year":"2009","unstructured":"Marazza G, Pham HC, Scharer L, Pedrazzetti PP, Hunziker T, Trueb RM, Hohl D, Itin P, Lautenschlager S, Naldi L, Borradori L: Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol. 2009, 161: 861-868.","journal-title":"Br J Dermatol"},{"key":"476_CR6","first-page":"434","volume":"7","author":"F Bertram","year":"2009","unstructured":"Bertram F, Brocker EB, Zillikens D, Schmidt E: Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges. 2009, 7: 434-440.","journal-title":"J Dtsch Dermatol Ges"},{"key":"476_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.det.2011.06.011","volume":"29","author":"C Chams-Davatchi","year":"2011","unstructured":"Chams-Davatchi C: Prevalence and treatment of pemphigus in Iran. Dermatol Clin. 2011, 29: 681-683.","journal-title":"Dermatol Clin"},{"key":"476_CR8","doi-asserted-by":"publisher","first-page":"a180","DOI":"10.1136\/bmj.a180","volume":"337","author":"SM Langan","year":"2008","unstructured":"Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J: Bullous pemphigoid and pemphigus vulgaris\u2013incidence and mortality in the UK: population based cohort study. BMJ. 2008, 337: a180.","journal-title":"BMJ"},{"key":"476_CR9","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/jid.2012.35","volume":"132","author":"P Joly","year":"2012","unstructured":"Joly P, Baricault S, Sparsa A, Bernard P, Bedane C, Duvert-Lehembre S, Courville P, Bravard P, Remond B, Doffoel-Hantz V, Benichou J: Incidence and Mortality of Bullous Pemphigoid in France. J Invest Dermatol. 2012, 132: 1998-2004.","journal-title":"J Invest Dermatol"},{"key":"476_CR10","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S0190-9622(99)70061-7","volume":"41","author":"M Jung","year":"1999","unstructured":"Jung M, Kippes W, Messer G, Zillikens D, Rzany B: Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence. J Am Acad Dermatol. 1999, 41: 266-268.","journal-title":"J Am Acad Dermatol"},{"key":"476_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1046\/j.1468-3083.2002.00384.x","volume":"16","author":"K Hahn-Ristic","year":"2002","unstructured":"Hahn-Ristic K, Rzany B, Amagai M, Brocker EB, Zillikens D: Increased incidence of pemphigus vulgaris in southern Europeans living in Germany compared with native Germans. J Eur Acad Dermatol Venereol. 2002, 16: 68-71.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"476_CR12","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1365-4632.2009.04345.x","volume":"49","author":"A Baican","year":"2010","unstructured":"Baican A, Baican C, Chiriac G, Chiriac MT, Macovei V, Zillikens D, Ciuce D, Sitaru C: Pemphigus vulgaris is the most common autoimmune bullous disease in Northwestern Romania. Int J Dermatol. 2010, 49: 768-774.","journal-title":"Int J Dermatol"},{"key":"476_CR13","first-page":"370","volume":"138","author":"LS Chan","year":"2002","unstructured":"Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, Fine JD, Foster CS, Ghohestani R, Hashimoto T, et al: The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002, 138: 370-379.","journal-title":"Arch Dermatol"},{"key":"476_CR14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1067\/mjd.2001.117518","volume":"45","author":"DF Mutasim","year":"2001","unstructured":"Mutasim DF, Adams BB: Immunofluorescence in dermatology. J Am Acad Dermatol. 2001, 45: 803-822.","journal-title":"J Am Acad Dermatol"},{"key":"476_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.autrev.2010.08.007","volume":"10","author":"E Schmidt","year":"2010","unstructured":"Schmidt E, Zillikens D: Modern diagnosis of autoimmune blistering skin diseases. Autoimmun Rev. 2010, 10: 84-89.","journal-title":"Autoimmun Rev"},{"key":"476_CR16","first-page":"127","volume":"146","author":"G Pohla-Gubo","year":"2011","unstructured":"Pohla-Gubo G, Kraus L, Hintner H: Role of immunofluorescence microscopy in dermatology. G Ital Dermatol Venereol. 2011, 146: 127-142.","journal-title":"G Ital Dermatol Venereol"},{"key":"476_CR17","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.159.4.2010","volume":"159","author":"K Ishii","year":"1997","unstructured":"Ishii K, Amagai M, Hall RP, Hashimoto T, Takayanagi A, Gamou S, Shimizu N, Nishikawa T: Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol. 1997, 159: 2010-2017.","journal-title":"J Immunol"},{"key":"476_CR18","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1046\/j.1365-2133.2001.04132.x","volume":"144","author":"KE Harman","year":"2001","unstructured":"Harman KE, Seed PT, Gratian MJ, Bhogal BS, Challacombe SJ, Black MM: The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol. 2001, 144: 775-780.","journal-title":"Br J Dermatol"},{"key":"476_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jdermsci.2005.11.002","volume":"41","author":"M Yoshida","year":"2006","unstructured":"Yoshida M, Hamada T, Amagai M, Hashimoto K, Uehara R, Yamaguchi K, Imamura K, Okamoto E, Yasumoto S, Hashimoto T: Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid. J Dermatol Sci. 2006, 41: 21-30.","journal-title":"J Dermatol Sci"},{"key":"476_CR20","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1600-0625.2007.00592.x","volume":"16","author":"C Sitaru","year":"2007","unstructured":"Sitaru C, Dahnrich C, Probst C, Komorowski L, Blocker I, Schmidt E, Schlumberger W, Rose C, St\u00f6cker W, Zillikens D: Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies. Exp Dermatol. 2007, 16: 770-777.","journal-title":"Exp Dermatol"},{"key":"476_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cca.2009.08.022","volume":"410","author":"C Probst","year":"2009","unstructured":"Probst C, Schlumberger W, St\u00f6cker W, Recke A, Schmidt E, Hashimoto T, Zhu XJ, Zillikens D, Komorowski L: Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus. Clin Chim Acta. 2009, 410: 13-18.","journal-title":"Clin Chim Acta"},{"key":"476_CR22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1600-0625.2010.01069.x","volume":"19","author":"E Schmidt","year":"2010","unstructured":"Schmidt E, Dahnrich C, Rosemann A, Probst C, Komorowski L, Saschenbrecker S, Schlumberger W, Stocker W, Hashimoto T, Brocker EB, et al: Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients. Exp Dermatol. 2010, 19: 458-463.","journal-title":"Exp Dermatol"},{"key":"476_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jdermsci.2011.03.003","volume":"62","author":"MA Saleh","year":"2011","unstructured":"Saleh MA, Ishii K, Kim YJ, Murakami A, Ishii N, Hashimoto T, Schmidt E, Zillikens D, Shirakata Y, Hashimoto K, et al: Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients. J Dermatol Sci. 2011, 62: 169-175.","journal-title":"J Dermatol Sci"},{"key":"476_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/1523-1747.ep12470131","volume":"88","author":"ML Sabolinski","year":"1987","unstructured":"Sabolinski ML, Beutner EH, Krasny S, Kumar V, Huang J, Chorzelski TP, Sampaio S, Bystryn JC: Substrate specificity of anti-epithelial antibodies of pemphigus vulgaris and pemphigus foliaceus sera in immunofluorescence tests on monkey and guinea pig esophagus sections. J Invest Dermatol. 1987, 88: 545-549.","journal-title":"J Invest Dermatol"},{"key":"476_CR25","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/0190-9622(90)70094-X","volume":"22","author":"WR Gammon","year":"1990","unstructured":"Gammon WR, Kowalewski C, Chorzelski TP, Kumar V, Briggaman RA, Beutner EH: Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. J Am Acad Dermatol. 1990, 22: 664-670.","journal-title":"J Am Acad Dermatol"},{"key":"476_CR26","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1001\/archderm.1997.03890450048006","volume":"133","author":"RF Ghohestani","year":"1997","unstructured":"Ghohestani RF, Nicolas JF, Rousselle P, Claudy AL: Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses. Arch Dermatol. 1997, 133: 1102-1107.","journal-title":"Arch Dermatol"},{"key":"476_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0190-9622(97)80127-2","volume":"37","author":"D Jiao","year":"1997","unstructured":"Jiao D, Bystryn JC: Sensitivity of indirect immunofluorescence, substrate specificity, and immunoblotting in the diagnosis of pemphigus. J Am Acad Dermatol. 1997, 37: 211-216.","journal-title":"J Am Acad Dermatol"},{"key":"476_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1749-6632.2009.04744.x","volume":"1173","author":"E Schmidt","year":"2009","unstructured":"Schmidt E, Goebeler M, Zillikens D: Rituximab in severe pemphigus. Ann N Y Acad Sci. 2009, 1173: 683-691.","journal-title":"Ann N Y Acad Sci"},{"key":"476_CR29","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1046\/j.1365-2133.2003.05427.x","volume":"149","author":"C Sitaru","year":"2003","unstructured":"Sitaru C, Powell J, Shimanovich I, Jainta S, Kirtschig G, Wojnarowska F, Zillikens D: Pemphigoid gestationis: maternal sera recognize epitopes restricted to the N-terminal portion of the extracellular domain of BP180 not present on its shed ectodomain. Br J Dermatol. 2003, 149: 420-422.","journal-title":"Br J Dermatol"},{"key":"476_CR30","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0923-1811(02)00109-3","volume":"30","author":"M Kobayashi","year":"2002","unstructured":"Kobayashi M, Amagai M, Kuroda-Kinoshita K, Hashimoto T, Shirakata Y, Hashimoto K, Nishikawa T: BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid. J Dermatol Sci. 2002, 30: 224-232.","journal-title":"J Dermatol Sci"},{"key":"476_CR31","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.clim.2003.12.007","volume":"111","author":"A Kromminga","year":"2004","unstructured":"Kromminga A, Sitaru C, Hagel C, Herzog S, Zillikens D: Development of an ELISA for the detection of autoantibodies to BP230. Clin Immunol. 2004, 111: 146-152.","journal-title":"Clin Immunol"},{"key":"476_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jaad.2011.02.025","volume":"66","author":"M Kasperkiewicz","year":"2011","unstructured":"Kasperkiewicz M, Dahnrich C, Probst C, Komorowski L, Stocker W, Schlumberger W, Zillikens D, Rose C: Novel assay for detecting celiac disease-associated autoantibodies in dermatitis herpetiformis using deamidated gliadin-analogous fusion peptides. J Am Acad Dermatol. 2011, 66: 583-588.","journal-title":"J Am Acad Dermatol"},{"key":"476_CR33","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1046\/j.1365-2133.2001.04471.x","volume":"145","author":"E Schmidt","year":"2001","unstructured":"Schmidt E, Skrobek C, Kromminga A, Hashimoto T, Messer G, Brocker EB, Yancey KB, Zillikens D: Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180. Br J Dermatol. 2001, 145: 778-783.","journal-title":"Br J Dermatol"},{"key":"476_CR34","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/1523-1747.ep12349283","volume":"106","author":"D Zillikens","year":"1996","unstructured":"Zillikens D, Kawahara Y, Ishiko A, Shimizu H, Mayer J, Rank CV, Liu Z, Giudice GJ, Tran HH, Marinkovich MP, et al: A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. J Invest Dermatol. 1996, 106: 1333-1338.","journal-title":"J Invest Dermatol"},{"key":"476_CR35","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.jaad.2004.06.004","volume":"51","author":"Z Lazarova","year":"2004","unstructured":"Lazarova Z, Sitaru C, Zillikens D, Yancey KB: Comparative analysis of methods for detection of anti-laminin 5 autoantibodies in patients with anti-epiligrin cicatricial pemphigoid. J Am Acad Dermatol. 2004, 51: 886-892.","journal-title":"J Am Acad Dermatol"},{"key":"476_CR36","volume-title":"J Am Acad Dermatol","author":"L Komorowski","year":"2012","unstructured":"Komorowski L, M\u00fcller R, Vorobyev A, Probst C, Recke A, Jonkman MF, Hashimoto T, Kim S-C, Groves R, Ludwig RJ, et al: Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita. J Am Acad Dermatol. 2012, Epub ahead of print"},{"key":"476_CR37","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2133.2010.10056.x","volume":"164","author":"S Groth","year":"2011","unstructured":"Groth S, Recke A, Vafia K, Ludwig RJ, Hashimoto T, Zillikens D, Schmidt E: Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid. Br J Dermatol. 2011, 164: 76-82.","journal-title":"Br J Dermatol"},{"key":"476_CR38","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.det.2011.06.007","volume":"29","author":"E Schmidt","year":"2011","unstructured":"Schmidt E, Zillikens D: Diagnosis and treatment of patients with autoimmune bullous disorders in Germany. Dermatol Clin. 2011, 29: 663-671.","journal-title":"Dermatol Clin"},{"key":"476_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/001316446002000104","volume":"20","author":"J Cohen","year":"1960","unstructured":"Cohen J: A coefficient of agreement for nominal scales. Educational and Psychological Measurements. 1960, 20: 37-46.","journal-title":"Educational and Psychological Measurements"},{"key":"476_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics. 1977, 33: 159-174.","journal-title":"Biometrics"},{"key":"476_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-6-31","volume":"6","author":"K Csorba","year":"2011","unstructured":"Csorba K, Schmidt S, Florea F, Ishii N, Hashimoto T, Hertl M, Karpati S, Bruckner-Tuderman L, Nishie W, Sitaru C: Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases. Orphanet J Rare Dis. 2011, 6: 31.","journal-title":"Orphanet J Rare Dis"},{"key":"476_CR42","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1073\/pnas.0809230106","volume":"106","author":"T Dainichi","year":"2008","unstructured":"Dainichi T, Kurono S, Ohyama B, Ishii N, Sanzen N, Hayashi M, Shimono C, Taniguchi Y, Koga H, Karashima T, et al: Anti-laminin gamma-1 pemphigoid. PNAS. 2008, 106: 2800-2805.","journal-title":"PNAS"},{"key":"476_CR43","doi-asserted-by":"publisher","first-page":"e12250","DOI":"10.1371\/journal.pone.0012250","volume":"5","author":"I Schepens","year":"2010","unstructured":"Schepens I, Jaunin F, Begre N, Laderach U, Marcus K, Hashimoto T, Favre B, Borradori L: The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human. PLoS One. 2010, 5: e12250.","journal-title":"PLoS One"},{"key":"476_CR44","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1365-2133.2009.09566.x","volume":"162","author":"S Grootenboer-Mignot","year":"2010","unstructured":"Grootenboer-Mignot S, Descamps V, Picard-Dahan C, Nicaise-Roland P, Prost-Squarcioni C, Leroux-Villet C, Champagnat C, Delaval A, Aucouturier F, Crickx B, Chollet-Martin S: Place of human amniotic membrane immunoblotting in the diagnosis of autoimmune bullous dermatoses. Br J Dermatol. 2010, 162: 743-750.","journal-title":"Br J Dermatol"},{"key":"476_CR45","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1046\/j.1365-2133.2000.03838.x","volume":"143","author":"CW Lee","year":"2000","unstructured":"Lee CW: An extract of cultured A431 cells contains major tissue antigens of autoimmune bullous diseases. Br J Dermatol. 2000, 143: 821-823.","journal-title":"Br J Dermatol"},{"key":"476_CR46","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","volume":"323","author":"GJ Anhalt","year":"1990","unstructured":"Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, Izumi H, Ratrie H, Mutasim D, Ariss-Abdo L, et al: Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 1990, 323: 1729-1735.","journal-title":"N Engl J Med"},{"key":"476_CR47","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/S0140-6736(00)04971-0","volume":"357","author":"CA Egan","year":"2001","unstructured":"Egan CA, Lazarova Z, Darling TN, Yee C, Cote T, Yancey KB: Anti-epiligrin cicatricial pemphigoid and relative risk for cancer. Lancet. 2001, 357: 1850-1851.","journal-title":"Lancet"},{"key":"476_CR48","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1001\/archderm.138.3.380","volume":"138","author":"G Kirtschig","year":"2002","unstructured":"Kirtschig G, Murrell D, Wojnarowska F, Khumalo N: Interventions for mucous membrane pemphigoid\/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review. Arch Dermatol. 2002, 138: 380-384.","journal-title":"Arch Dermatol"},{"key":"476_CR49","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jaad.2010.04.039","volume":"64","author":"LK Martin","year":"2011","unstructured":"Martin LK, Werth VP, Villaneuva EV, Murrell DF: A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus. J Am Acad Dermatol. 2011, 64: 903-908.","journal-title":"J Am Acad Dermatol"},{"key":"476_CR50","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/jid.2008.412","volume":"129","author":"P Joly","year":"2009","unstructured":"Joly P, Roujeau JC, Benichou J, Delaporte E, D'Incan M, Dreno B, Bedane C, Sparsa A, Gorin I, Picard C, et al: A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. J Invest Dermatol. 2009, 129: 1681-1687.","journal-title":"J Invest Dermatol"},{"key":"476_CR51","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/j.1365-2133.2012.10820.x","volume":"166","author":"IM Blocker","year":"2012","unstructured":"Blocker IM, Dahnrich C, Probst C, Komorowski L, Saschenbrecker S, Schlumberger W, Stocker W, Zillikens D, Schmidt E: Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid. Br J Dermatol. 2012, 166: 964-970.","journal-title":"Br J Dermatol"},{"key":"476_CR52","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1001\/archdermatol.2011.23","volume":"147","author":"J Charneux","year":"2011","unstructured":"Charneux J, Lorin J, Vitry F, Antonicelli F, Reguiai Z, Barbe C, Tabary T, Grange F, Bernard P: Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients. Arch Dermatol. 2011, 147: 286-291.","journal-title":"Arch Dermatol"},{"key":"476_CR53","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1006\/jaut.2002.0589","volume":"18","author":"E Schmidt","year":"2002","unstructured":"Schmidt E, Kromminga A, Mimietz S, Leinfelder U, Sitaru C, Brocker EB, Zillikens D, Zimmermann U: A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180. J Autoimmun. 2002, 18: 299-309.","journal-title":"J Autoimmun"},{"key":"476_CR54","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1038\/jid.2009.41","volume":"129","author":"PM Sharma","year":"2009","unstructured":"Sharma PM, Choi EJ, Kuroda K, Hachiya T, Ishii K, Payne AS: Pathogenic anti-desmoglein MAbs show variable ELISA activity because of preferential binding of mature versus proprotein isoforms of desmoglein 3. J Invest Dermatol. 2009, 129: 2309-2312.","journal-title":"J Invest Dermatol"},{"key":"476_CR55","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1038\/jid.2009.61","volume":"129","author":"M Yokouchi","year":"2009","unstructured":"Yokouchi M, Saleh MA, Kuroda K, Hachiya T, Stanley JR, Amagai M, Ishii K: Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of prosequence. J Invest Dermatol. 2009, 129: 2156-2166.","journal-title":"J Invest Dermatol"},{"key":"476_CR56","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1006\/jaut.2000.0437","volume":"15","author":"A Kromminga","year":"2000","unstructured":"Kromminga A, Scheckenbach C, Georgi M, Hagel C, Arndt R, Christophers E, Brocker EB, Zillikens D: Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180. J Autoimmun. 2000, 15: 293-300.","journal-title":"J Autoimmun"},{"key":"476_CR57","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1046\/j.1365-2133.2000.03661.x","volume":"143","author":"S Christophoridis","year":"2000","unstructured":"Christophoridis S, Budinger L, Borradori L, Hunziker T, Merk HF, Hertl M: IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis. Br J Dermatol. 2000, 143: 349-355.","journal-title":"Br J Dermatol"},{"key":"476_CR58","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1365-2133.2011.10346.x","volume":"165","author":"JJ Buijsrogge","year":"2011","unstructured":"Buijsrogge JJ, Diercks GF, Pas HH, Jonkman MF: The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy. Br J Dermatol. 2011, 165: 92-98.","journal-title":"Br J Dermatol"},{"key":"476_CR59","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.clim.2008.04.012","volume":"128","author":"G Di Zenzo","year":"2008","unstructured":"Di Zenzo G, Thoma-Uszynski S, Fontao L, Calabresi V, Hofmann SC, Hellmark T, Sebbag N, Pedicelli C, Sera F, Lacour JP, et al: Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid. Clin Immunol. 2008, 128: 415-426.","journal-title":"Clin Immunol"},{"key":"476_CR60","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/archdermatol.2011.21","volume":"147","author":"A Roussel","year":"2011","unstructured":"Roussel A, Benichou J, Randriamanantany ZA, Gilbert D, Drenovska K, Houivet E, Tron F, Joly P: Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid. Arch Dermatol. 2011, 147: 293-298.","journal-title":"Arch Dermatol"},{"key":"476_CR61","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1001\/archdermatol.2011.23","volume":"147","author":"J Charneux","year":"2011","unstructured":"Charneux J, Lorin J, Vitry F, Antonicelli F, Reguiai Z, Barbe C, Tabary T, Grange F, Bernard P: Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients. Arch Dermatol. 2011, 147: 286-291.","journal-title":"Arch Dermatol"},{"key":"476_CR62","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/archderm.136.2.174","volume":"136","author":"E Schmidt","year":"2000","unstructured":"Schmidt E, Obe K, Brocker EB, Zillikens D: Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol. 2000, 136: 174-178.","journal-title":"Arch Dermatol"},{"key":"476_CR63","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.det.2011.03.013","volume":"29","author":"VA Venning","year":"2011","unstructured":"Venning VA: Linear IgA disease: clinical presentation, diagnosis, and pathogenesis. Dermatol Clin. 2011, 29: 453-458. ix","journal-title":"Dermatol Clin"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-7-49.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T03:13:33Z","timestamp":1687662813000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-7-49"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,9]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["476"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-7-49","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.722427441.793510935","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,9]]},"assertion":[{"value":"7 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"49"}}